European Journal of Surgical Oncology (EJSO),

A systematic review of risk-reducing cancer surgery outcomes for hereditary cancer syndromes

Publication date: Available online 25 June 2019Source: European Journal of Surgical OncologyAuthor(s): Oliver Peacock, Peadar S. Waters, Jaime Otero de Pablos, Alex Boussioutas, Anita Skandarajah, Jonathan A. Simpson, Satish K. Warrier, Alexander G. HeriotAbstractCancer predisposition genes are rare mutations that confer a high risk of cancer. For many hereditary cancer syndromes, risk reducing surgery is the single most effective strategy for preventing cancer, but it is irreversible. It has recently...

European Journal of Surgical Oncology (EJSO)

15h

Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis

Publication date: Available online 25 June 2019Source: European Journal of Surgical OncologyAuthor(s): Zhen-Hua Chen, Xiu-Ping Zhang, Teng-Fei Zhou, Kang Wang, Hang Wang, Zong-Tao Chai, Jie Shi, Wei-Xing Guo, Shu-Qun ChengAbstractBackgroundThe benefits of adjuvant transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) patients with microvascular invasion (MVI) remain controversial. We compared the efficacy and safety of adjuvant TACE and hepatic resection (HR) alone for HCC patients...

European Journal of Surgical Oncology (EJSO)

15h